Literature DB >> 15208940

Furin expression in squamous cell carcinomas of the oral cavity and other sites evaluated by tissue microarray technology.

R López de Cicco1, D E Bassi, R Page, A J Klein-Szanto.   

Abstract

Furin is a proprotein convertase that activates many cancer development-related substrates such as growth factors, growth factor-receptors, adhesion molecules, and matrix degrading enzymes. Furin expression was studied in sections from tissue microarrays (TMA) and conventional paraffin blocks in a collection of squamous cell carcinomas (SCC) from three different sites. A total of 118 SCCs from the oral cavity, lung and esophagus as well as 34 precursor lesions (intraepithelial neoplasia) from the oral and bronchial mucosae were studied by immunohistochemistry. Furin expression was notably higher in most precursor lesions than in normal epithelia. Tumors from either the TMAs or the conventional blocks showed significant differences when compared to the mostly negative normal epithelia. High levels of furin expression were observed in approximately 50% SCCs of three different sites as well as in precursor lesions of the oral and bronchial mucosae. In addition another 30% showed low furin expression that was localized in all tumor cells including those in a basaloid position. Normal epithelia sometimes showed low level expression but the normal basal cells were always negative. These results show that furin is up-regulated in SCCs from three different organs and validates its use as a tumor marker in both invasive and pre-invasive neoplasia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15208940

Source DB:  PubMed          Journal:  Acta Odontol Latinoam        ISSN: 0326-4815


  11 in total

1.  Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer.

Authors:  Kristin A Spivey; Jacqueline Banyard; Luisa M Solis; Ignacio I Wistuba; Justine A Barletta; Leena Gandhi; Henry A Feldman; Scott J Rodig; Lucian R Chirieac; Bruce R Zetter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

2.  The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer.

Authors:  Abdel-Majid Khatib; John W M Creemers; Zongsheng He; Lieven Thorrez; Geraldine Siegfried; Sandra Meulemans; Serge Evrard; Sabine Tejpar
Journal:  Oncogene       Date:  2020-03-06       Impact factor: 9.867

3.  Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth.

Authors:  Daniel E Bassi; Jirong Zhang; Catherine Renner; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2016-09-22       Impact factor: 4.784

Review 4.  Endo/exo-proteolysis in neoplastic progression and metastasis.

Authors:  Abdel-Majid Khatib; Daniel Bassi; Geraldine Siegfried; Andres J P Klein-Szanto; L'Houcine Ouafik
Journal:  J Mol Med (Berl)       Date:  2005-08-26       Impact factor: 4.599

5.  Enhanced UV-induced skin carcinogenesis in transgenic mice overexpressing proprotein convertases.

Authors:  Jian Fu; Daniel E Bassi; Jirong Zhang; Tianyu Li; Kathy Q Cai; Courtney Lyons Testa; Emmanuelle Nicolas; Andres J Klein-Szanto
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

6.  Transgenic overexpression of the proprotein convertase furin enhances skin tumor growth.

Authors:  Jian Fu; Daniel E Bassi; Jirong Zhang; Tianyu Li; Emmanuelle Nicolas; Andres J P Klein-Szanto
Journal:  Neoplasia       Date:  2012-04       Impact factor: 5.715

7.  Increased susceptibility of SARS-CoV2 infection on oral cancer patients; cause and effects: An hypothesis.

Authors:  Anshika Chauhan; Sushmita Ghoshal; Arnab Pal
Journal:  Med Hypotheses       Date:  2020-06-09       Impact factor: 1.538

8.  Streptococcus endopeptidases promote HPV infection in vitro.

Authors:  Sylvia I Pavlova; Reid V Wilkening; Michael J Federle; Yu Lu; Joel Schwartz; Lin Tao
Journal:  Microbiologyopen       Date:  2018-04-19       Impact factor: 3.139

9.  Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies.

Authors:  Akalesh Kumar Verma; Vikas Kumar; Sweta Singh; Bhabesh Ch Goswami; Ihosvany Camps; Aishwarya Sekar; Sanghwa Yoon; Keun Woo Lee
Journal:  Biomed Pharmacother       Date:  2021-02-03       Impact factor: 7.419

10.  Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A.

Authors:  Gilad Kaplan; Fred Lee; Masanori Onda; Emily Kolyvas; Gaurav Bhardwaj; David Baker; Ira Pastan
Journal:  Toxins (Basel)       Date:  2016-07-25       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.